{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,2]],"date-time":"2025-08-02T16:50:13Z","timestamp":1754153413417,"version":"3.41.2"},"reference-count":29,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2009,11,1]],"date-time":"2009-11-01T00:00:00Z","timestamp":1257033600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,11,1]],"date-time":"2009-11-01T00:00:00Z","timestamp":1257033600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2009,11,1]],"date-time":"2009-11-01T00:00:00Z","timestamp":1257033600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["international-journal-of-gynecological-cancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Gynecological Cancer"],"published-print":{"date-parts":[[2009,11]]},"DOI":"10.1111\/igc.0b013e3181b7662d","type":"journal-article","created":{"date-parts":[[2010,12,3]],"date-time":"2010-12-03T13:48:52Z","timestamp":1291384132000},"page":"1314-1321","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Risk of Hospitalizations Associated With Adverse Effects of Chemotherapy in a Large Community-Based Cohort of Elderly Women With Ovarian Cancer"],"prefix":"10.1016","volume":"19","author":[{"given":"Zhannat","family":"Nurgalieva","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chih-Chin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xianglin L.","family":"Du","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1111\/IGC.0b013e3181b7662d_bb0005","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1097\/00130404-200511000-00002","article-title":"Population aging and cancer: a cross-national concern","volume":"11","author":"Yancik","year":"2005","journal-title":"Cancer J."},{"issue":"suppl 2","key":"10.1111\/IGC.0b013e3181b7662d_bb0010","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1081\/CNV-200030113","article-title":"Update on Gynecologic Oncology Group (GOG) trials in ovarian cancer","volume":"22","author":"Ozols","year":"2004","journal-title":"Cancer Invest."},{"key":"10.1111\/IGC.0b013e3181b7662d_bb0015","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.tips.2008.07.007","article-title":"Antineoplastic agents in the management of ovarian cancer: current status and emerging therapeutic strategies","volume":"29","author":"Markman","year":"2008","journal-title":"Trends Pharmacol Sci."},{"key":"10.1111\/IGC.0b013e3181b7662d_bb0020","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1136\/ijgc-00009577-200807000-00010","article-title":"Ethnic differences in socioeconomic status, diagnosis, treatment, and survival among older women with epithelial ovarian cancer","volume":"18","author":"Du","year":"2008","journal-title":"Int J Gynecol Cancer."},{"key":"10.1111\/IGC.0b013e3181b7662d_bb0025","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1097\/00000446-200601000-00032","article-title":"Functional decline in hospitalized older adults","volume":"106","author":"Graf","year":"2006","journal-title":"Am J Nurs."},{"issue":"18S","key":"10.1111\/IGC.0b013e3181b7662d_bb0030","doi-asserted-by":"crossref","first-page":"9035","DOI":"10.1200\/jco.2007.25.18_suppl.9035","article-title":"Risk factors for hospitalization in elderly cancer patients receiving chemotherapy","volume":"25","author":"Kleiner","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1111\/IGC.0b013e3181b7662d_bb0035","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1200\/JCO.2003.08.065","article-title":"Patterns of chemotherapy use for women with ovarian cancer: a population-based study","volume":"21","author":"Cress","year":"2003","journal-title":"J Clin Oncol."},{"key":"10.1111\/IGC.0b013e3181b7662d_bb0040","doi-asserted-by":"crossref","first-page":"2201","DOI":"10.1111\/j.1475-6773.2006.00596.x","article-title":"Variation in chemotherapy utilization in ovarian cancer: the relative contribution of geography","volume":"41","author":"Polsky","year":"2006","journal-title":"Health Serv Res."},{"key":"10.1111\/IGC.0b013e3181b7662d_bb0045","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1200\/JCO.2002.20.1.173","article-title":"Variations in the use of chemotherapy for elderly patients with advanced ovarian cancer: a population-based study","volume":"20","author":"Sundararajan","year":"2002","journal-title":"J Clin Oncol."},{"year":"2008","series-title":"SEER Cancer Statistics Review, 1975\u20132005","author":"Ries","key":"10.1111\/IGC.0b013e3181b7662d_bb0050"},{"key":"10.1111\/IGC.0b013e3181b7662d_bb0055","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1097\/00005650-199308000-00006","article-title":"Potential for cancer related health services research using a linked Medicare-tumor registry database","volume":"31","author":"Potosky","year":"1993","journal-title":"Med Care."},{"year":"1994","series-title":"The SEER Program Code Manual (Revised Ed)","author":"National Cancer Institute","key":"10.1111\/IGC.0b013e3181b7662d_bb0060"},{"year":"2000","series-title":"Data User Reference Guide (DURG)","author":"Health Care Financing Administration","key":"10.1111\/IGC.0b013e3181b7662d_bb0065"},{"key":"10.1111\/IGC.0b013e3181b7662d_bb0070","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A new method of classifying prognostic comorbidity in longitudinal studies: development and validation","volume":"40","author":"Charlson","year":"1987","journal-title":"J Chronic Dis."},{"key":"10.1111\/IGC.0b013e3181b7662d_bb0075","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1016\/0895-4356(93)90103-8","article-title":"Adapting a clinical comorbidity index for use with ICD-9-CM administrative data: differing perspectives","volume":"46","author":"Romano","year":"1993","journal-title":"J Clin Epidemiol."},{"year":"1997","series-title":"Categorical Data Analysis Using the SAS System","author":"Stokes","key":"10.1111\/IGC.0b013e3181b7662d_bb0080"},{"key":"10.1111\/IGC.0b013e3181b7662d_bb0085","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1006\/gyno.1998.5158","article-title":"Gastrointestinal toxicity and Clostridium difficile diarrhea in patients treated with paclitaxel-containing chemotherapy regimens","volume":"71","author":"Husain","year":"1998","journal-title":"Gynecol Oncol."},{"key":"10.1111\/IGC.0b013e3181b7662d_bb0090","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1097\/00000421-199402000-00016","article-title":"High-risk early-stage ovarian cancer. Randomized clinical trial comparing cisplatin plus cyclophosphamide versus whole abdominal radiotherapy","volume":"17","author":"Chiara","year":"1994","journal-title":"Am J Clin Oncol."},{"key":"10.1111\/IGC.0b013e3181b7662d_bb0095","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1006\/gyno.1995.1140","article-title":"Intestinal perforation secondary to paclitaxel","volume":"57","author":"Rose","year":"1995","journal-title":"Gynecol Oncol."},{"key":"10.1111\/IGC.0b013e3181b7662d_bb0100","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1093\/jnci\/89.8.582-a","article-title":"Fatal hepatic coma attributed to paclitaxel","volume":"89","author":"Feenstra","year":"1997","journal-title":"J Natl Cancer Inst."},{"key":"10.1111\/IGC.0b013e3181b7662d_bb0105","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1634\/theoncologist.12-4-478","article-title":"Evaluating the total costs of chemotherapy-induced febrile neutropenia: results from a pilot study with community oncology cancer patients","volume":"12","author":"Bennett","year":"2007","journal-title":"Oncologist."},{"key":"10.1111\/IGC.0b013e3181b7662d_bb0110","first-page":"105","article-title":"Immediate and long-term toxicity of adjuvant chemotherapy regimens containing doxorubicin in trials at M.D. Anderson Hospital and Tumor Institute","volume":"1","author":"Hortobagyi","year":"1986","journal-title":"NCI Monogr."},{"key":"10.1111\/IGC.0b013e3181b7662d_bb0115","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.ygyno.2006.02.012","article-title":"Characterization of neutropenic fever in patients receiving first-line adjuvant chemotherapy for epithelial ovarian cancer","volume":"103","author":"Sharma","year":"2006","journal-title":"Gynecol Oncol."},{"key":"10.1111\/IGC.0b013e3181b7662d_bb0120","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1093\/jnci\/djh323","article-title":"Phase III randomized trial of docetaxel-carboplatin versus paclitaxel-carboplatin as first-line chemotherapy for ovarian carcinoma","volume":"96","author":"Vasey","year":"2004","journal-title":"J Natl Cancer Inst."},{"key":"10.1111\/IGC.0b013e3181b7662d_bb0125","doi-asserted-by":"crossref","first-page":"4528","DOI":"10.1200\/JCO.2006.10.4752","article-title":"Pharmacogenetic assessment of toxicity and outcome after platinum plus taxane chemotherapy in ovarian cancer: the Scottish Randomised Trial in Ovarian Cancer","volume":"25","author":"Marsh","year":"2007","journal-title":"J Clin Oncol."},{"key":"10.1111\/IGC.0b013e3181b7662d_bb0130","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1002\/(SICI)1097-0142(19960215)77:4<733::AID-CNCR20>3.0.CO;2-0","article-title":"Randomized trial of initial therapy with melphalan versus cisplatin-based combination chemotherapy in patients with advanced ovarian carcinoma: initial and long term results\u2014Eastern Cooperative Oncology Group Study E2878","volume":"77","author":"Wadler","year":"1996","journal-title":"Cancer."},{"key":"10.1111\/IGC.0b013e3181b7662d_bb0135","doi-asserted-by":"crossref","first-page":"195","DOI":"10.3747\/co.2007.148","article-title":"Optimal chemotherapy treatment for women with recurrent ovarian cancer","volume":"14","author":"Fung-Kee-Fung","year":"2007","journal-title":"Curr Oncol."},{"key":"10.1111\/IGC.0b013e3181b7662d_bb0140","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1200\/JCO.1994.12.11.2301","article-title":"Phase II trial of docetaxel in patients with platinum-refractory advanced ovarian cancer","volume":"12","author":"Francis","year":"1994","journal-title":"J Clin Oncol."},{"key":"10.1111\/IGC.0b013e3181b7662d_bb0145","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.ygyno.2008.01.001","article-title":"Improved tolerance of primary chemotherapy with reduced-dose carboplatin and paclitaxel in elderly ovarian cancer patients","volume":"109","author":"Fader","year":"2008","journal-title":"Gynecol Oncol."}],"container-title":["International Journal of Gynecological Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2FIGC.0b013e3181b7662d","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X24028032?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X24028032?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,23]],"date-time":"2025-07-23T01:17:17Z","timestamp":1753233437000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1048891X24028032"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,11]]},"references-count":29,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2009,11]]}},"alternative-id":["S1048891X24028032"],"URL":"https:\/\/doi.org\/10.1111\/igc.0b013e3181b7662d","relation":{},"ISSN":["1048-891X"],"issn-type":[{"type":"print","value":"1048-891X"}],"subject":[],"published":{"date-parts":[[2009,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Risk of Hospitalizations Associated With Adverse Effects of Chemotherapy in a Large Community-Based Cohort of Elderly Women With Ovarian Cancer","name":"articletitle","label":"Article Title"},{"value":"International Journal of Gynecological Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/IGC.0b013e3181b7662d","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 by IGCS and ESGO","name":"copyright","label":"Copyright"}]}}